Ensign Peak Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Ensign Peak Advisors's HALO Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Halozyme (HALO) stake by 0.8% in Q3 2026, selling an estimated $4.83K and leaving 6,218 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #860.
Ensign Peak Advisors first reported a position in HALO in Q4 2019 and has held it in 28 quarters since. The position peaked at $12.9M in Q3 2023. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Ensign Peak Advisors held 6,218 shares of Halozyme worth $686K as of Q3 2026.
- Ensign Peak Advisors sold 50 Halozyme shares in Q3 2026, an estimated $4.83K.
- Halozyme made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #860 holding.
- Ensign Peak Advisors first reported a position in Halozyme in Q4 2019 and has held it in 28 quarters since.
- Ensign Peak Advisors's Halozyme position peaked at $12.9M in Q3 2023.
- 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.